FENOFIBRATE MICRO 200 MG — DIN 02286092
FENOFIBRATE : 200 MG · SANIS HEALTH INC · CAPSULE · wholesale supply in Canada
Health Canada status: CANCELLED POST MARKET
What is FENOFIBRATE MICRO?
FENOFIBRATE MICRO 200 MG contains FENOFIBRATE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02286092, held by SANIS HEALTH INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
How much does Fenofibrate cost around the world?
Fenofibrate is listed on 9 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Greece publishes a producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 13 | 105 | USD███.██ |
| Australia | ex-manufacturer | 11 | 36 | AUD███.██ |
| Saudi Arabia | public | 11 | 17 | SAR███.██ |
| Bahrain | retail (max) | 6 | 7 | BHD███.██ |
| Morocco | PPV (public price) | 3 | 6 | MAD███.██ |
| South Africa | single exit price | 3 | 3 | ZAR███.██ |
| Greece | producer price (ex-factory) | 2 | 2 | EUR███.██ |
| United Arab Emirates | public | 1 | 1 | AED███.██ |
| Iceland | max wholesale | 1 | 1 | ISK███.██ |
178 pack listings across 51 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every Fenofibrate pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Fenofibrate in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
21 holders have a Canadian DIN containing Fenofibrate, across 56 DINs, of which 10 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 6 | 4 | AA-FENO-MICRO, AA-FENO-SUPER, FENOFIBRATE | Sourceable in Canada |
| BGP PHARMA ULC | 4 | 3 | LIPIDIL EZ, LIPIDIL MICRO, LIPIDIL SUPRA | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 5 | 2 | SANDOZ FENOFIBRATE E, SANDOZ FENOFIBRATE S | Sourceable in Canada |
| SUN PHARMA CANADA INC | 1 | 1 | SN-FENOFIBRATE E | Sourceable in Canada |
| PHARMASCIENCE INC | 5 | 0 | PMS-FENOFIBRATE, PMS-FENOFIBRATE MICRO, PMS-FENOFIBRATE SUPRA | No marketed DIN |
| TEVA CANADA LIMITED | 5 | 0 | NTP-FENOFIBRATE-S, RATIO-FENOFIBRATE MC, TEVA-FENOFIBRATE-S | No marketed DIN |
| DOMINION PHARMACAL | 3 | 0 | DOM-FENOFIBRATE MICRO, DOM-FENOFIBRATE SUPRA | No marketed DIN |
| LABORATOIRES FOURNIER S.A.S. | 3 | 0 | LIPIDIL CAP 100MG, LIPIDIL MICRO - CAP 67MG, LIPIDIL SUPRA 100 MG | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | NOVO-FENOFIBRATE, NOVO-FENOFIBRATE MICRONIZED | No marketed DIN |
| PHARMEL INC | 3 | 0 | PHL-FENOFIBRATE MICRO, PHL-FENOFIBRATE SUPRA | No marketed DIN |
| PRO DOC LIMITEE | 3 | 0 | FENO-MICRO-200, PRO-FENO-SUPER - 100, PRO-FENO-SUPER - 160 | No marketed DIN |
| SANIS HEALTH INC | 3 | 0 | FENOFIBRATE MICRO, FENOFIBRATE-S | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 200 MG |
|---|---|
| Dosage form | CAPSULE |
| Route | ORAL |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Fenofibrate |
|---|---|
| ATC code | C10AB05 |
| AHFS class | 56:28.12 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02286092 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2286092 |
| Brand name | FENOFIBRATE MICRO |
| Generic / active ingredient | FENOFIBRATE : 200 MG |
| Market authorization holder | SANIS HEALTH INC |
| Health Canada schedule | Prescription |
| ATC code | C10AB05 |
| ATC anatomical main group | C — Cardiovascular system |
| ATC therapeutic subgroup | C10AB |
| Current status | CANCELLED POST MARKET |
| Status date | 31-Jul-2017 |
| Original market date | 2009-10-22 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
10 of 56 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| AA-FENO-MICRO | 200 MG | CAPSULE | AA PHARMA INC | MARKETED | 02239864 |
| AA-FENO-MICRO | 67 MG | CAPSULE | AA PHARMA INC | MARKETED | 02243180 |
| AA-FENO-SUPER | 160 MG | TABLET | AA PHARMA INC | MARKETED | 02246860 |
| AA-FENO-SUPER | 100 MG | TABLET | AA PHARMA INC | MARKETED | 02246859 |
| LIPIDIL EZ | 145 MG | TABLET | BGP PHARMA ULC | MARKETED | 02269082 |
| LIPIDIL EZ | 48 MG | TABLET | BGP PHARMA ULC | MARKETED | 02269074 |
| LIPIDIL SUPRA | 160 MG | TABLET | BGP PHARMA ULC | MARKETED | 02241602 |
| SANDOZ FENOFIBRATE E | 48.0 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | 02390698 |
| SANDOZ FENOFIBRATE E | 145.0 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED | 02390701 |
| SN-FENOFIBRATE E | 145 MG | TABLET | SUN PHARMA CANADA INC | MARKETED | 02454696 |
2 · Same class — other molecules in ATC C10AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Fenofibrate | AA-FENO-MICRO · AA-FENO-SUPER · AVA-FENOFIBRATE MICRO · DOM-FENOFIBRATE MICRO · DOM-FENOFIBRATE SUPRA · FENO-MICRO-200 · FENOFIBRATE · FENOFIBRATE MICRO · FENOFIBRATE-S · FENOMAX · LIPIDIL CAP 100MG · LIPIDIL EZ · LIPIDIL MICRO · LIPIDIL MICRO - CAP 67MG · LIPIDIL SUPRA · LIPIDIL SUPRA 100 MG · MINT-FENOFIBRATE E · MYLAN-FENOFIBRATE MICRO · NOVO-FENOFIBRATE · NOVO-FENOFIBRATE MICRONIZED · NTP-FENOFIBRATE-S · NU-FENO-MICRO · PHL-FENOFIBRATE MICRO · PHL-FENOFIBRATE SUPRA · PMS-FENOFIBRATE · PMS-FENOFIBRATE MICRO · PMS-FENOFIBRATE SUPRA · PRO-FENO-SUPER - 100 · PRO-FENO-SUPER - 160 · Q-FENOFIBRATE MICRO · RAN-FENOFIBRATE S · RATIO-FENOFIBRATE MC · RIVA-FENOFIBRATE MICRO · SANDOZ FENOFIBRATE E · SANDOZ FENOFIBRATE S · SN-FENOFIBRATE E · TEVA-FENOFIBRATE-S | 56 | 10 | Yes |
| Bezafibrate | ACT-BEZAFIBRATE SR · BEZALIP SR · BEZALIP TAB 200MG · JAMP-BEZAFIBRATE SR · PMS-BEZAFIBRATE | 5 | 2 | Yes |
| Gemfibrozil | APO-GEMFIBROZIL · APO-GEMFIBROZIL CAP 300MG USP · DOM-GEMFIBROZIL · GEMFIBROZIL CAP 300MG · GEMFIBROZIL TAB 600MG · GEMFIBROZIL-300 - CAP · GEMFIBROZIL-600 - TAB 600MG · LOPID 600MG · LOPID CAP 300MG · MYLAN-GEMFIBROZIL · NU-GEMFIBROZIL CAP 300MG · NU-GEMFIBROZIL TAB 600MG · PHL-GEMFIBROZIL · PMS-GEMFIBROZIL · RIVA-GEMFIBROZIL · SCHEINPHARM GEMFIBROZIL · TEVA-GEMFIBROZIL | 22 | 1 | Yes |
| Clofibrate | ATROMID S CAP 500MG · ATROMID-S 1GM · ATROMID-S CAP 500MG · NOVO-FIBRATE CAP 500MG | 4 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC C10A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| C10AA | Atorvastatin · Cerivastatin · Fluvastatin · Lovastatin · Pravastatin · Rosuvastatin · Simvastatin | 759 | 286 |
| C10AX | Alirocumab · Dextrothyroxine · Evinacumab · Evolocumab · Ezetimibe · Inclisiran · Lomitapide · Omega-3-Triglycerides Incl. Other Esters And Acids · Omega-3-Triglycerides, Combinations · Probucol | 48 | 28 |
| C10AC | Colesevelam · Colestipol · Colestyramine | 29 | 6 |
| C10AD | Nicotinic Acid | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is FENOFIBRATE MICRO called?
The same molecule, Fenofibrate, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| LIPANTHYL | Latin | Bahrain, Morocco |
| APO-Fenofibrate | Latin | Australia |
| ARX-FENOFIBRATE | Latin | Australia |
| Fenofibrate Lupin | Latin | Australia |
| FENOFIBRATE RBX | Latin | Australia |
| Fenofibrate Viatris | Latin | Australia |
| FENOFIBRATE-WGR | Latin | Australia |
| Lipidil | Latin | Australia |
| Lipofirate | Latin | Saudi Arabia |
| BTC Fenofibrate | Latin | Australia |
| Fenocol | Latin | Australia |
| Fenofibrate Cipla | Latin | Australia |
| Fenofibrate Sandoz | Latin | Australia |
| LOFAT | Latin | Morocco |
| LYPFEN | Latin | Bahrain, Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.